NCTY - The9 Limited

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
7,223
17,432
73,149
56,199
Cost of Revenue
8,186
16,436
23,782
48,519
Gross Profit
-963
996
49,367
7,681
Operating Expenses
Research Development
21,041
24,555
45,112
77,991
Selling General and Administrative
96,708
91,909
117,915
150,334
Total Operating Expenses
117,610
116,235
162,677
228,326
Operating Income or Loss
-118,573
-115,239
-113,311
-220,645
Interest Expense
70,859
104,777
83,922
56,472
Total Other Income/Expenses Net
-10,382
-15,171
27,498
-285,678
Income Before Tax
-199,620
-234,992
-169,704
-562,634
Income Tax Expense
-
0
0
-6,079
Income from Continuing Operations
-204,110
-239,285
-112,093
-667,090
Net Income
-182,584
-217,093
-118,166
-593,782
Net Income available to common shareholders
-211,087
-258,012
-175,292
-676,672
Reported EPS
Basic
-
-12.45
-15.72
-85.02
Diluted
-
-12.45
-15.72
-85.02
Weighted average shares outstanding
Basic
-
20,705
11,142
7,958
Diluted
-
20,705
11,142
7,958
EBITDA
-
-124,644
-78,562
-486,772